Aliases & Classifications for Cellulitis

Summaries for Cellulitis

MedlinePlus : 41 cellulitis is an infection of the skin and deep underlying tissues. group a strep (streptococcal) bacteria are the most common cause. the bacteria enter your body when you get an injury such as a bruise, burn, surgical cut, or wound. symptoms include fever and chills swollen glands or lymph nodes a rash with painful, red, tender skin. the skin may blister and scab over. your health care provider may take a sample or culture from your skin or do a blood test to identify the bacteria causing infection. treatment is with antibiotics. they may be oral in mild cases, or intravenous (by iv) for more severe cases. nih: national institute of allergy and infectious diseases

MalaCards based summary : Cellulitis is related to subacute bacterial endocarditis and skin disease, and has symptoms including exanthema, fever and pruritus. An important gene associated with Cellulitis is IL5 (Interleukin 5), and among its related pathways/superpathways are Bacterial infections in CF airways and Hematopoietic cell lineage. The drugs Penicillin V and Daptomycin have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and lymph node.

Disease Ontology : 12 A skin disease where there is a diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin. Cellulitis can be caused by normal skin flora or by exogenous bacteria, and often occurs where the skin has previously been broken

Wikipedia : 72 Cellulitis is a bacterial infection involving the inner layers of the skin. It specifically affects the... more...

Related Diseases for Cellulitis

Diseases related to Cellulitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 364)
id Related Disease Score Top Affiliating Genes
1 subacute bacterial endocarditis 30.0 IL5 RNASE3
2 skin disease 29.6 DEFB4A IL5 RNASE3
3 polyarteritis nodosa 29.4 CRP TNF
4 rheumatoid arthritis 29.0 CHI3L1 CRP IL1R1 TNF
5 pulmonary embolism 28.9 CRP LACTB TNF
6 orbital cellulitis 12.3
7 wells syndrome 11.6
8 perifolliculitis capitis abscedens et suffodiens, familial 11.5
9 tinea unguium 11.2
10 erysipelas 11.1
11 ludwig's angina 11.1
12 parametritis 11.1
13 erysipeloid 11.0
14 nocardiosis 11.0
15 walker dyson syndrome 10.8 IL1R1 TNF
16 aortic arch interruption 10.8 IL5 TNF
17 papillary follicular thyroid adenocarcinoma 10.8 IL5 RNASE3
18 collagenous gastritis 10.7 IL1R1 RNASE3
19 toxic diffuse goiter 10.7 IL5 RNASE3
20 urethral intrinsic sphincter deficiency 10.7 IL5 TNF
21 marasmus 10.7 IL5 RNASE3
22 hepatic encephalopathy 10.7 IL5 TNF
23 x-linked intellectual disability, van esch type 10.7 IL5 RNASE3
24 crustacean allergy 10.7 IL5 RNASE3
25 orbital plasma cell granuloma 10.7 IL5 RNASE3
26 lacrimal duct defect 10.7
27 whim syndrome 10.7
28 fusariosis 10.7
29 hereditary lymphedema 10.7
30 clear cell acanthoma 10.7
31 elizabethkingia anophelis infection 10.7
32 hereditary lymphedema type ii 10.7
33 winchester syndrome 10.7 IL5 RNASE3
34 apple allergy 10.7 IL5 RNASE3
35 purpura fulminans 10.7 IL5 RNASE3
36 lymphocytic gastritis 10.7 IL5 RNASE3
37 cannabis abuse 10.7 IL5 RNASE3
38 acute gonococcal prostatitis 10.7 IL5 RNASE3
39 trachea leiomyoma 10.7 IL5 RNASE3
40 exophthalmos 10.6 IL5 RNASE3
41 female urethral cancer 10.6 IL5 RNASE3
42 dentin caries 10.5 IL1R1 IL5 RNASE3
43 viljoen kallis voges syndrome 10.5 IL5 RNASE3
44 glioblastoma multiforme 10.5 IL5 RNASE3 TNF
45 dehydration polycythemia 10.5 IL5 RNASE3 TNF
46 sublingual gland cancer 10.5 IL5 RNASE3 TNF
47 pelvic varices 10.5 IL5 RNASE3 TNF
48 fuchs' heterochromic uveitis 10.5 IL5 RNASE3 TNF
49 spontaneous ocular nystagmus 10.5 IL5 RNASE3 TNF
50 uterus interstitial leiomyoma 10.5 IL5 RNASE3 TNF

Graphical network of the top 20 diseases related to Cellulitis:



Diseases related to Cellulitis

Symptoms & Phenotypes for Cellulitis

UMLS symptoms related to Cellulitis:


exanthema, fever, pruritus

Drugs & Therapeutics for Cellulitis

Drugs for Cellulitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 169)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
2
Daptomycin Approved, Investigational Phase 4,Phase 2 103060-53-3 16129629
3
Vancomycin Approved Phase 4,Phase 3,Phase 2 1404-90-6 441141 14969
4
Oxacillin Approved Phase 4,Phase 2 66-79-5 6196
5
Thrombin Approved Phase 4
6
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3 18323-44-9 29029
7
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
8
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
9
Lenograstim Approved Phase 4 135968-09-1
10
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
11
Lincomycin Approved, Vet_approved Phase 4 154-21-2 656509
12 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
13 Anti-Infective Agents Phase 4,Phase 3,Phase 2
14 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
15 penicillins Phase 4,Phase 2
16 Arginine Vasopressin Phase 4
17 Coagulants Phase 4
18 Hemostatics Phase 4
19 Natriuretic Agents Phase 4
20 Vasoconstrictor Agents Phase 4
21 Vasopressins Phase 4
22 acivicin Phase 4
23 Antitubercular Agents Phase 4
24 Antiviral Agents Phase 4
25 Respiratory System Agents Phase 4
26 Clindamycin palmitate Phase 4,Phase 2,Phase 3
27 Clindamycin phosphate Phase 4,Phase 2,Phase 3
28 Floxacillin Phase 4
29 methicillin Phase 4,Phase 2,Phase 3
30 Adjuvants, Immunologic Phase 4
31 Antidotes Phase 4
32 Antioxidants Phase 4
33 diuretics Phase 4
34 Expectorants Phase 4
35 Liver Extracts Phase 4
36 N-monoacetylcystine Phase 4
37 Pharmaceutical Solutions Phase 4,Phase 3
38 Protective Agents Phase 4
39 arginine Nutraceutical Phase 4
40 cysteine Nutraceutical Phase 4
41
Cefazolin Approved Phase 3,Phase 2 25953-19-9 656510 33255
42
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
43
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
44
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
45
Norgestimate Approved Phase 3 35189-28-7 6540478
46
Probenecid Approved Phase 3,Phase 2 57-66-9 4911
47
Ciprofloxacin Approved, Investigational Phase 2, Phase 3 85721-33-1 2764
48
Levofloxacin Approved, Investigational Phase 2, Phase 3 100986-85-4 149096
49
Ofloxacin Approved Phase 2, Phase 3 82419-36-1 4583
50
Cilastatin Approved Phase 3 82009-34-5 5280454 6435415

Interventional clinical trials:

(show top 50) (show all 119)

id Name Status NCT ID Phase Drugs
1 RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Completed NCT00552799 Phase 4 Penicillin VK
2 Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Completed NCT00295178 Phase 4 Daptomycin;Vancomycin
3 The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin Completed NCT01626560 Phase 4 Daptomycin;Vancomycin
4 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Completed NCT01549613 Phase 4 Daptomycin;Vancomycin
5 Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial Completed NCT00799292 Phase 4 Vasopressin
6 Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions Completed NCT02137447 Phase 4
7 A Complicated Skin and Soft-tissue Infection Patient Registry Completed NCT00737269 Phase 4
8 Study of Wound Packing After Superficial Skin Abscess Drainage Completed NCT00746109 Phase 4
9 Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty Completed NCT01410240 Phase 4 FLOSEAL Hemostatic Matrix + Standard of care
10 The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair Recruiting NCT02688634 Phase 4 Amoxicillin
11 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4 standard medical therapy;G-CSF;n-Acetylcysteine
12 Adjunctive Clindamycin for Cellulitis: C4C Trial. Active, not recruiting NCT01876628 Phase 4 Flucloxacillin and Clindamycin;Flucloxacillin and placebo
13 Penicillin for the Emergency Department Outpatient Treatment of CELLulitis Not yet recruiting NCT02922686 Phase 4 Flucloxacillin;Phenoxymethylpenicillin;Placebo (for phenoxymethylpenicillin)
14 Duration of ANtibiotic Therapy for CEllulitis Terminated NCT02032654 Phase 4 Flucloxacillin;Placebo (for flucloxacillin)
15 Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections Terminated NCT00463801 Phase 4 Daptomycin
16 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
17 Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department Unknown status NCT00323219 Phase 3 Cefazolin and Moxifloxacin
18 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin Completed NCT00257036 Phase 2, Phase 3 levofloxacin
19 Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses Completed NCT01085929 Phase 3
20 Complicated Skin and Skin Structure Infections Completed NCT00619710 Phase 3 Meropenem;Imipenem-cilastatin
21 Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Completed NCT00729937 Phase 2, Phase 3 Cephalexin;Clindamycin;Trimethoprim-sulfamethoxazole
22 Evaluation of the Activity of a Pharmacological "Anticellulitis" Product vs. a Reference Product on the Market Completed NCT02195297 Phase 3
23 Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT02127970 Phase 3 Single Dose Dalbavancin;Two Dose Dalbavancin
24 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT01431339 Phase 3 IV Dalbavancin;Vancomycin/Linezolid
25 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT01339091 Phase 3 Dalbavancin;Vancomycin / Linezolid
26 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252732 Phase 3 Single-Dose IV Oritavancin Diphosphate;IV Vancomycin
27 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252719 Phase 3 Single-Dose IV Oritavancin Diphosphate;IV Vancomycin
28 Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses Completed NCT00973765 Phase 3 bactrim;placebo
29 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT01576367 Phase 3
30 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT01302860 Phase 3 ACZ885
31 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Completed NCT00991146 Phase 3 canakinumab
32 Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT00685373 Phase 3 Canakinumab (ACZ885)
33 Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome Completed NCT00465985 Phase 3 ACZ885;Placebo
34 Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections Completed NCT01499277 Phase 3 Ceftaroline fosamil;Vancomycin;Aztreonam
35 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00424190 Phase 3 IV Vancomycin plus IV Aztreonam;Ceftaroline
36 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00423657 Phase 3 ceftaroline;vancomycin plus aztreonam;Placebo
37 A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age Completed NCT02545543 Phase 3
38 A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. Completed NCT02214225 Phase 3
39 A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. Completed NCT02914275 Phase 3
40 Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) Terminated NCT00865280 Phase 3 PTK 0796;linezolid
41 Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. Terminated NCT02202135 Phase 3 Ceftaroline fosamil;Vancomycin;Aztreonam
42 Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Terminated NCT00577317 Phase 3
43 Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) Withdrawn NCT00876850 Phase 3 PTK 0796;Linezolid
44 Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis Completed NCT01029782 Phase 2 IV cefazolin plus oral probenecid and placebo cephalexin;Oral cephalexin and saline IV plus probenecid placebo
45 A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study Completed NCT01519778 Phase 2 TR701 FA
46 Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Completed NCT00730028 Phase 2 Trimethoprim-sulfamethoxazole;Clindamycin
47 Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage Completed NCT00984022 Phase 2
48 The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study Completed NCT01770509 Phase 1, Phase 2
49 A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci Completed NCT01519492 Phase 2 AFN-12520000
50 A Study for Patients With Complicated Skin and Skin Structure Infections Completed NCT00514527 Phase 2 oritavancin

Search NIH Clinical Center for Cellulitis

Cochrane evidence based reviews: cellulitis

Genetic Tests for Cellulitis

Genetic tests related to Cellulitis:

id Genetic test Affiliating Genes
1 Cellulitis 29

Anatomical Context for Cellulitis

MalaCards organs/tissues related to Cellulitis:

39
Skin, Testes, Lymph Node, Breast, Bone, Eye, T Cells

Publications for Cellulitis

Articles related to Cellulitis:

(show top 50) (show all 1120)
id Title Authors Year
1
Management of orbital cellulitis and subperiosteal orbital abscess in pediatric patients: A ten-year review. ( 28390618 )
2017
2
No Benefit with Addition of TMP/SMX to Cephalexin for Nonpurulent Cellulitis. ( 28925641 )
2017
3
Acute Sickle Cell Orbitopathy Masquerading as Orbital Cellulitis. ( 28816800 )
2017
4
Invasive <em>Neisseria gonorrhoeae</em> producing pre-septal cellulitis and keratoconjunctivitis: diagnosis and management. ( 28899333 )
2017
5
The Penicillin for the Emergency Department Outpatient treatment of CELLulitis (PEDOCELL) trial: update to the study protocol and detailed statistical analysis plan (SAP). ( 28836993 )
2017
6
Identifying priority areas for research into the diagnosis, treatment and prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership. ( 28477399 )
2017
7
Odontogenic orbital cellulitis associated with cavernous sinus thrombosis and pulmonary embolism: a case report. ( 28629401 )
2017
8
Orbital Perivenous Abscess Complicating the Diagnosis and Management of Orbital Cellulitis. ( 28481768 )
2017
9
Orbital Cellulitis Following Uncomplicated Aqueous Shunt Surgery. ( 28557827 )
2017
10
Orbital cellulitis due to ophthalmic herpes zoster in an immunocompetent child: A case report. ( 28802683 )
2017
11
Orbital Cellulitis in a Psoriatic Patient Treated With Adalimumab. ( 28290979 )
2017
12
Chronic Helicobacter cinaedi cellulitis diagnosed by microbial polymerase chain reaction. ( 28884138 )
2017
13
Orbital cellulitis from facial tissue fillers. ( 28186379 )
2017
14
Paediatric orbital cellulitis and the relationship to underlying sinonasal anatomy on computed tomography. ( 28683847 )
2017
15
Anaphylactoid Purpura Associated with Streptococcal Cellulitis: A Case Report and Literature Review. ( 28900445 )
2017
16
Disseminated cryptococcosis presenting as cellulitis. ( 27779149 )
2017
17
Management of impetigo and cellulitis: Simple considerations for promoting appropriate antibiotic use in skin infections. ( 28807958 )
2017
18
SUBTENON AMIKACIN INJECTION FOR THE TREATMENT OF NOCARDIA ASTEROIDES ORBITAL CELLULITIS IN A PATIENT WITH A HISTORY OF SCLERAL BUCKLING. ( 28925928 )
2017
19
Cutaneous polyarteritis nodosa localized to a region of lymphedema secondary to Streptococcus viridans cellulitis and multiple surgeries. ( 27862152 )
2017
20
Cellulitis in aged persons: a neglected infection in the literature. ( 28904688 )
2017
21
Clinical characteristics associated with days to discharge among patients admitted with a primary diagnosis of lower limb cellulitis. ( 28089727 )
2017
22
Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. ( 28575438 )
2017
23
Clinical profile and outcomes of management of orbital cellulitis in Upper Egypt. ( 28275981 )
2017
24
Interventions for the prevention of recurrent erysipelas and cellulitis. ( 28631307 )
2017
25
Serum anti-oxidative reserves during cellulitis: a pilot study. ( 28862136 )
2017
26
Orbital Cellulitis Following Uncomplicated Aqueous Shunt Surgery. ( 28557824 )
2017
27
Bullous Pesentation of Idiopathic Wells Syndrome (Eosinophilic Cellulitis). ( 28920134 )
2017
28
Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing. ( 28919346 )
2017
29
Scabies, Periorbital Cellulitis and Recurrent Skin Abscesses due to Panton-Valentine Leukocidin Positive S. aureus Mimic Hyper IgE Syndrome in an Infant. ( 28938255 )
2017
30
Intravenous Steroids With Antibiotics on Admission for Children With Orbital Cellulitis. ( 28369021 )
2017
31
Sarcoidosis and Wound Healing After Cellulitis of the Lower Limb: Is Methotrexate Responsible for Skin Graft Failure? ( 28862976 )
2017
32
Serum Immune Proteins in Limb Lymphedema Reflecting Tissue Processes Caused by Lymph Stasis and Chronic Dermato-lymphangio-adenitis (Cellulitis). ( 28880710 )
2017
33
Varicella complicated by cellulitis and deep vein thrombosis. ( 28882940 )
2017
34
Skin surface temperatures measured by thermal imaging aid in the diagnosis of cellulitis. ( 28951240 )
2017
35
Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis. ( 28194321 )
2017
36
Case of recurrent severe cellulitis and cutaneous candidiasis during psoriasis treatment with ustekinumab. ( 28432713 )
2017
37
Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study. ( 28944703 )
2017
38
Orbital Cellulitis Following Orbital Blow-out Fracture. ( 28806382 )
2017
39
Necrotic Intraocular Retinoblastoma Associated With Orbital Cellulitis. ( 28254446 )
2017
40
Infective Endocarditis Presenting as Bilateral Orbital Cellulitis: An Unusual Case. ( 28721318 )
2017
41
Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis. ( 28874503 )
2017
42
Low sensitivity of needle aspiration cultures in patients with cellulitis/erysipelas. ( 27652151 )
2016
43
Cryptococcal cellulitis on the shin of an immunosuppressed patient. ( 27617599 )
2016
44
Cellulitis of the Knee in a 16-Month-Old Boy: A Case Report. ( 27069433 )
2016
45
Cutaneous Sporotrichosis Presenting as Clinical Feature of Facial Cellulitis in an Adult. ( 27489440 )
2016
46
Pediatric nasal orbital cellulitis in Shenzhen (South China): Etiology, management, and outcomes. ( 27368452 )
2016
47
Successful treatment of eosinophilic cellulitis with dapsone. ( 27617724 )
2016
48
Helicobacter cinaedi - an emerging form of cellulitis. ( 27484266 )
2016
49
Sphingobacterium spiritivorum septicaemia associated with cellulitis in a patient with Parkinson's disease. ( 27161206 )
2016
50
Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency? ( 27661464 )
2016

Variations for Cellulitis

Expression for Cellulitis

Search GEO for disease gene expression data for Cellulitis.

Pathways for Cellulitis

GO Terms for Cellulitis

Cellular components related to Cellulitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 CAMP CHI3L1 CRP DEFB4A IL5 RNASE3
2 extracellular region GO:0005576 9.28 CAMP CHI3L1 CRP DEFB4A FLT4 IL1R1

Biological processes related to Cellulitis according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.8 DEFB4A IL1R1 IL5 TNF
2 inflammatory response GO:0006954 9.73 CHI3L1 CRP IL5 TNF
3 defense response GO:0006952 9.63 CAMP DEFB4A TNF
4 innate immune response in mucosa GO:0002227 9.48 CAMP RNASE3
5 defense response to bacterium GO:0042742 9.46 CAMP DEFB4A RNASE3 TNF
6 negative regulation of growth of symbiont in host GO:0044130 9.4 CAMP TNF
7 positive regulation of podosome assembly GO:0071803 9.37 IL5 TNF
8 defense response to Gram-negative bacterium GO:0050829 9.32 CAMP DEFB4A
9 negative regulation of lipid storage GO:0010888 9.26 CRP TNF
10 antimicrobial humoral response GO:0019730 9.13 CAMP DEFB4A RNASE3
11 defense response to Gram-positive bacterium GO:0050830 9.02 CAMP CRP DEFB4A RNASE3 TNF

Sources for Cellulitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....